LEO 19123

Drug Profile

LEO 19123

Alternative Names: Calcipotriol/LEO 80122; LEO 19123 cream; LEO-19123

Latest Information Update: 28 Mar 2011

Price : $50

At a glance

  • Originator LEO Pharma
  • Class Skin disorder therapies
  • Mechanism of Action Calcitriol receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Plaque psoriasis
  • Discontinued Atopic dermatitis; Eczema

Most Recent Events

  • 25 Sep 2005 Preclinical trials in Eczema in Denmark (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top